Navigation Links
Meet the expert sessions at the 24th Annual EAU Congress
Date:3/12/2009

Arnhem, 12 March 2009 - At the forthcoming 24th Annual EAU Congress in Stockholm (SE), which will start on Tuesday 17 March, the EAU will be organizing three Meet the Expert sessions. These are press meetings on various subjects with expert urologists. They will be held in the Press Centre of the congress venue. In these sessions, members of the press have the opportunity to ask the experts their questions practically one-on-one.

The first session's subject is Male incontinence and will be organised on Wednesday 18 March from 15:00 to 15:30 hours. It is chaired by Prof Paul Abrams who will discuss the latest developments in this area. He is considered one of the world's leading experts in the field of lower urinary tract dysfunction. He is currently Professor of Urology, University of Bristol (UK). Paul Abrams has served as General Secretary of the International Continence Society (ICS). He was Chairman of the International WHO Consultations on Incontinence.

Prof Kurt Naber will be chairing the second session about the International Consultation on Urological Diseases (ICUD) on Thursday 19 March 2009 from 14:30 to 15:00 hours. The ICUD is organising global consultations on urological diseases, under the cosponsorship of the World Health Organization (WHO), the International Society of Urology (SIU), and the International Union Against Cancer (UICC).

The aim of the ICUD is to improve, with concerted efforts, the management and reduce the prevalence of urinary tract infections as well as the development of bacterial resistance. Another objective is to arrive at a consensus, which will be laid down in a textbook on urogenital infections with contributions of an international faculty consisting of about 100 recognised experts.

Kurt Naber is Professor of Urology at the Technical University of Mnchen (GE), School of Medicine. He is an expert in urological infections, especially the treatment of urinary tract infections and prostatitis. He
'/>"/>

Contact: Lindy Brouwer
l.brouwer@uroweb.org
0031-263-890-680
European Association of Urology
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Umbilical cord clamping should be delayed, says expert
2. College Mental Health Expert and Sister of Student Who Died By Suicide Available to Discuss College Mental Health Issues
3. Expert on Emerging Infectious Zoonotic Diseases Joining K-State as a Regents Distinguished Professor
4. Research Links TV/Video Game Playing With Child Obesity; Health Experts Back a New Approach
5. AWWA, National Association of Water and Sanitation of Mexico, Agree to Share Expertise and Resources for Improved Water Supply
6. Euro RSCG Life Broadens X2 Expertise
7. MultiVu Video Feed: PUBLIC HEALTH EXPERTS CONVENE TO DISCUSS THE TREATMENT AND PREVENTION OF RABIES
8. Mayo Clinic to Pilot Collexis Expert Profiling
9. Health IT Event Draws Experts to the Pacific Northwest
10. Experts Sort Out Good Fats From Bad
11. Experts Offer Tips on Lung Cancer Prevention
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... Cumberland Pediatric Dentistry and Orthodontics ... values anxiety-free dental care for children, while maintaining the ... dental care. , The orthodontic team is committed ... adolescents, adults and those with special needs. Whether a ... require unique care, such as cleft palate, Cumberland Pediatric ...
(Date:7/22/2014)... (July 22, 2014) With over 170,000 students ... being exposed to injuries during practice and competition, according ... Public Health and the Center for Injury Research and ... The study, published online today by The American ... lacrosse players experienced 1,406 injuries over the four academic ...
(Date:7/22/2014)... July 22, 2014 Garland’s new ... designed to be used as a flood coat over ... or as a premium restoration material. It provides natural ... long-term performance and reducing life-cycle costs. Energizer BK is ... provide excellent water resistance in addition to superior strength ...
(Date:7/22/2014)... CareTouch Communications, Inc. has formed a ... Community . CareTouch employees will select causes they are ... in line with their mission to help people in ... first cause is Hike for Hospice, to benefit the ... September 14, the CareTouch in the Community team will ...
(Date:7/22/2014)... Most people encounter the same two problems when trying to ... is a fast metabolism. These are hard problems to counteract on ... help fight these problems and to finally gain weight. , The ... who just can’t seem to eat more than a couple bites ... cause of this problem can vary. For some it can be ...
Breaking Medicine News(10 mins):Health News:Cumberland Pediatric Dentistry and Orthodontics of Clarksville Welcomes Dr. Peter Wojtkiewicz, Pediatric Orthodontist 2Health News:Cumberland Pediatric Dentistry and Orthodontics of Clarksville Welcomes Dr. Peter Wojtkiewicz, Pediatric Orthodontist 3Health News:High school lacrosse players at risk of concussions other injuries 2Health News:High school lacrosse players at risk of concussions other injuries 3Health News:Energizer® BK Waterproof Coating from Garland Canada Reduces Life-Cycle Costs 2Health News:CareTouch is a Peak Sponsor for the 9th Annual Hike for Hospice in Morrison, Colorado 2Health News:CB-1 Weight Gainer Provides Two Tips to Help Customers Gain Weight 2
... **SAVE THE DATE** April 14-16, 2009 in ... www.worldhealthcarecongress.com WOBURN, Mass., Feb. 19 At ... top leaders and innovators who are driving the $2.4 ... Safeway, Carlson Companies and Kelly Services who are responsible ...
... Industry Veteran Will Lead Company in Development of ,Next ... 19 Valensa International has appointed Dr. Rudi E. ... company. The move to add CEO duties for Dr. ... Parry Nutraceuticals (Division of E.I.D. Parry (India) Ltd, Chennai, ...
... of ApoE4 gene in offspring makes a difference, study finds, ... parents had Alzheimer,s and who carry the so-called Alzheimer,s gene ... older, a new study has found. , This memory decline ... had Alzheimer,s but who do not carry the gene, ...
... VAR ) today announced that it has received ... to help doctors to improve,treatments and outcomes in many cancer ... radiation to control and manage tumors while,significantly reducing damage to ... "CE mark is an important milestone in Varian,s initiative to ...
... BOSTON, Feb. 19 Solos Endoscopy, Inc. (Pink ... Company,s breast endoscopy product line, the MammoView(TM), ... Surgical Products Magazine in the December 2008 issue. ... allow Physicians direct visualization, while examining lesions in ...
... SAN FRANCISCO, Calif., Feb. 19 Poniard Pharmaceuticals, Inc. ... on the development of innovative oncology products, today announced ... and senior vice president, effective February 18, 2009. Mr. ... operations of the Company. "Mr. Weaver has broad experience ...
Cached Medicine News:Health News:6th Annual World Health Care Congress to Convene Preeminent Leaders for Three Days on Rebuilding Health Care 2Health News:6th Annual World Health Care Congress to Convene Preeminent Leaders for Three Days on Rebuilding Health Care 3Health News:Valensa International's Dr. Rudi E. Moerck Appointed CEO 2Health News:If Parents Had Alzheimer's, Aging May Come Early 2Health News:If Parents Had Alzheimer's, Aging May Come Early 3Health News:Varian Medical Systems Has Received CE Mark for Proton Therapy System 2Health News:Solos Endoscopy, Inc.'s MammoView(TM) Featured in December Issue of Surgical Products Magazine 2Health News:Poniard Pharmaceuticals Announces Appointment of Greg Weaver as Chief Financial Officer 2Health News:Poniard Pharmaceuticals Announces Appointment of Greg Weaver as Chief Financial Officer 3
(Date:7/21/2014)... LA JOLLA, Calif. , July 21, 2014 ... RGLS ), a biopharmaceutical company leading the discovery ... today that the U.S. Food & Drug Administration ... a single stranded, chemically modified oligonucleotide that binds ... as a therapeutic for the treatment of Alport ...
(Date:7/21/2014)... , July 21, 2014  Valeant Pharmaceuticals ... (TSX: VRX) has contacted both the Autorite des ... and the U.S. Securities and Exchange Commission ... ) apparent attempt to mislead investors and manipulate ... to make false and misleading statements regarding Valeant,s ...
(Date:7/21/2014)... , July 21, 2014  CASI Pharmaceuticals, Inc. (Nasdaq: ... therapeutics for the treatment of cancer and other diseases, ... and Drug Administration (CFDA) has approved the Company,s application ... breast cancer (TNBC) patients in China ... Ken K. Ren , Ph.D., CASI,s Chief ...
Breaking Medicine Technology:Regulus Receives Orphan Drug Designation for RG-012, a microRNA Therapeutic for the Treatment of Alport Syndrome 2Regulus Receives Orphan Drug Designation for RG-012, a microRNA Therapeutic for the Treatment of Alport Syndrome 3Regulus Receives Orphan Drug Designation for RG-012, a microRNA Therapeutic for the Treatment of Alport Syndrome 4Regulus Receives Orphan Drug Designation for RG-012, a microRNA Therapeutic for the Treatment of Alport Syndrome 5Valeant Pharmaceuticals Contacts Quebec and U.S. Regulators About Allergan's False and Misleading Statements 2Valeant Pharmaceuticals Contacts Quebec and U.S. Regulators About Allergan's False and Misleading Statements 3Valeant Pharmaceuticals Contacts Quebec and U.S. Regulators About Allergan's False and Misleading Statements 4Valeant Pharmaceuticals Contacts Quebec and U.S. Regulators About Allergan's False and Misleading Statements 5Valeant Pharmaceuticals Contacts Quebec and U.S. Regulators About Allergan's False and Misleading Statements 6Valeant Pharmaceuticals Contacts Quebec and U.S. Regulators About Allergan's False and Misleading Statements 7CASI Pharmaceuticals Receives Approval From CFDA To Conduct Phase II Clinical Trial With ENMD-2076 For Triple-Negative Breast Cancer In China 2CASI Pharmaceuticals Receives Approval From CFDA To Conduct Phase II Clinical Trial With ENMD-2076 For Triple-Negative Breast Cancer In China 3CASI Pharmaceuticals Receives Approval From CFDA To Conduct Phase II Clinical Trial With ENMD-2076 For Triple-Negative Breast Cancer In China 4
Used in conjunction with the E5381 600 Circling Band (40 style). Indications: Narrow scleral bed. Overall length: 100 mm, 3.9 inches....
Used in conjunction with the E5381 600 Circling Band (40 style). Indications: Narrow scleral bed. Overall length: 100 mm, 3.9 inches....
...
...
Medicine Products: